Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
It is a common complaint that science journalists misrepresent genetics stories. The blame probably lies as much with geneticists themselves as with the reporters, and this article provides guidelines for getting the message across to journalists accurately.
Instead of taking a single-stakeholder perspective, the authors propose that a systematic approach that takes into account multiple stakeholders and their sometimes overlapping interests should be taken to facilitate decisions about genomic data sharing.
New approaches to the derivation of human embryonic stem cells are being developed, with the aim of getting around the ethical questions that surround standard techniques. But are any of these new methods really free from ethical objections?
Translational research for rare genetic diseases often suffers from a lack of funding. Advocacy groups that support individuals who are affected by such conditions are well placed to motivate and coordinate research that is aimed squarely at generating translational advances.
To ensure that the benefits of genomics reach all patients, primary health-care providers must be fully aware of current genomic and genetic issues and technologies. This article looks at what needs to be done to achieve this.
New developments in genomics require changes in the policies of various government bodies to address the legal and ethical implications of genomics and prioritize research and educational needs. This article surveys the changes that have been and need to be made.
With genetics and genomics moving at such a fast pace it is difficult to know where to find accurate and up-to-date information. This is a guide to online resources about genetics, which are aimed at teachers, students, health professionals and the general public.
The genetic profiling of babies could revolutionize health-care strategies. However, this possibility raises serious issues of consent, confidentiality and discrimination that need to be considered with great care.
The authors explore how human dignity is used in debates about controversial biotechnologies, including biobanks, human gene patents, stem cell research and human cloning, in light of shifting views of what human dignity is actually taken to mean.